⚖UPC-Intel
🏛️ EPO Munich

EPO T 0238/25

Court
EPO Board of Appeal 3.3.04 (Munich)
Type of action
opposition appeal
Patent
Peptidoglycan hydrolase for use in the treatment of chronic bacterial infections
Language
en
Claimant / applicant
  • Lysando AG
Defendant / respondent
  • Gleiss Große Schrell und Partner mbB
  • Strawman Limited

Track this case

Get an email when a new order or decision is published in EPO T 0238/25.

Decisions and documents (1)

Weekly digest

A weekly email summarising new published decisions across European patent courts.